Boxer Capital’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,300,000
| Closed | -$43.6M | – | 2 |
|
|
2024
Q3 | $43.6M | Hold |
1,300,000
| – | – | 2.14% | 15 |
|
|
2024
Q2 | $32.6M | Hold |
1,300,000
| – | – | 1.72% | 17 |
|
|
2024
Q1 | $29.3M | Hold |
1,300,000
| – | – | 1.45% | 21 |
|
|
2023
Q4 | $27.8M | Hold |
1,300,000
| – | – | 1.39% | 22 |
|
|
2023
Q3 | $23.3M | Hold |
1,300,000
| – | – | 1.24% | 28 |
|
|
2023
Q2 | $26.4M | Hold |
1,300,000
| – | – | 1.23% | 29 |
|
|
2023
Q1 | $28.3M | Hold |
1,300,000
| – | – | 1.39% | 23 |
|
|
2022
Q4 | $40.3M | Hold |
1,300,000
| – | – | 2.12% | 15 |
|
|
2022
Q3 | $33.2M | Hold |
1,300,000
| – | – | 1.87% | 18 |
|
|
2022
Q2 | $26.4M | Hold |
1,300,000
| – | – | 1.67% | 22 |
|
|
2022
Q1 | $32.2M | Hold |
1,300,000
| – | – | 1.65% | 20 |
|
|
2021
Q4 | $45.2M | Hold |
1,300,000
| – | – | 1.75% | 17 |
|
|
2021
Q3 | $35.3M | Hold |
1,300,000
| – | – | 1.23% | 25 |
|
|
2021
Q2 | $33.7M | Hold |
1,300,000
| – | – | 1.19% | 22 |
|
|
2021
Q1 | $28M | Hold |
1,300,000
| – | – | 0.95% | 32 |
|
|
2020
Q4 | $28M | Hold |
1,300,000
| – | – | 0.9% | 32 |
|
|
2020
Q3 | $19.2M | Hold |
1,300,000
| – | – | 0.66% | 37 |
|
|
2020
Q2 | $29M | Hold |
1,300,000
| – | – | 1.28% | 30 |
|
|
2020
Q1 | $18.4M | Hold |
1,300,000
| – | – | 1.25% | 24 |
|
|
2019
Q4 | $21.1M | Buy |
+1,300,000
| New | +$21.1M | 1.19% | 25 |
|
|
2017
Q2 | – | Sell |
-50,000
| Closed | -$1.39M | – | 30 |
|
|
2017
Q1 | $1.39M | Buy |
+50,000
| New | +$1.39M | 0.3% | 25 |
|